Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ClōSYS Regimen for Gingivitis and Periodontitis
NCT05258721Phase 2Completed
- Sponsor
- Rowpar Pharmaceuticals
- Start
- Jul 2021
- Primary completion
- Oct 2022
- Modality
- Inorganic Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of fluoride in gingivitis and periodontitis, sponsored by Rowpar Pharmaceuticals. Primary endpoints: Modified Gingival Index at 12 weeks, Plaque Index at 12 weeks and 1 more. Started Jul 2021; status: completed.
02
Drugs
fluoride
03
Conditions
gingivitisperiodontitis
Beyond the preview
Go deeper on NCT05258721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05258721.